ZHAN Qimin, MD, is currently an Academician of the Chinese Academy of Engineering, Chair of the Board, PKU Institute for Global Health and Development, Former President of Peking University Health Science Center, and the Director for Laboratory of Molecular Oncology. Dr. Zhan was the Chairman of the National Advisory Board for 863 High-Tech Plan in the field of biomedical sciences and is the Chief Scientist of the 973 National Fundamental Program. Dr. Zhan’s research interest is focused on the molecular pathways involved in the control of cell cycle and the signaling pathways involved in regulation of the maintenance of genomic stability and tumor metastasis. In the recent years, Dr. Zhan has paid great attention to the cancer translational study, including molecular diagnosis and personalized therapy. His research has successfully attracted multiple grants from different funding agencies. Dr. Zhan’s has published more than 270 peer-reviewed SCI papers. Many of his publications are in prestigious journals of the biomedical field, including Nature, Cell, Journal of Clinical Investigation, EMBO, Nat Communication, American J of Human Genetics, Cancer Research, Molecular Cancer and Oncogene. To date, these papers have been cited more than 14,000 times.